Alterations in plasma angiogenic growth factor concentrations after coronary artery bypass graft surgery: relationships with post-operative complications.

Y. Denizot,L. Guglielmi,E. Cornu,N. Nathan

DOI: https://doi.org/10.1016/S1043-4666(03)00241-2

IF: 3.926

2003-10-01

Cytokine

Abstract:

What problem does this paper attempt to address?

Paper based analytical devices for blood grouping: a comprehensive review

Saeed Ebrahimi Fana,Maliheh Paknejad,Mahdi Aminian

DOI: https://doi.org/10.1007/s10544-021-00569-w

2021-07-02

Abstract:The clinical importance of blood group (BG) antigens is related to their ability to induce immune antibodies that can cause hemolysis. Yet, ABO and D (Rh) are still considered to be the key antigens for healthy blood transfusion and secondary antigens are the next priority. Serological typing is the most widely used typing method. Rapid and accurate blood grouping plays an important role in some clinical conditions, rather than conventional techniques. Hence, developing a simple and economical model for rapid blood grouping would facilitate these tests. In recent decades, paper-based microfluidics such as μPADs has gained much interest in wide application areas such as point-of-care diagnostic. In this study, we evaluated μPADs that are performed for blood grouping and its recent progress. A comprehensive literature search was performed using databases including PUBMED, SCOPUS, Web of Science and Google Scholar. Keywords were blood grouping or typing, paper analytical device, rapid test, etc. After investigation of search results, 16 papers from 2010 to 2020 were included. Further information in detail was classified in Table 1. Generally, two principles for blood typing μPADs are introduced. The lateral chromatographic flow method and the vertical flow-through method that detects BG in a visual-based manner. To detect results with acceptable clarity many factors and challenges like paper, blood sample, buffer, Ab and RBC interaction and also μPADs stability need to be considered, which are discussed. In conclusion, the simplicity, stability, cheapness, portability and biocompatibility of μPADs for blood grouping confirming its utility and also they have the capability to robust, universal blood-grouping platform. Table 1 Summary of blood grouping tests using paper-based analytical devices Antigens Type of diagnosis Validation method Sample No Accuracy Action time Paper type Stability Sample dilution Buffer Ref A, B, Rh Forward volunteers records 5 - - Whatman No. 4 - 1/2 PBS* (Khan et al. 2010) A, B, Rh Forward gel assay test and conventional slide test 100 100% 1 min Whatman No. 4 and Kleeenex paper towel 7 Days in 4 °C 1/1 NSS (Al-Tamimi et al. 2012) A, B, Rh Forward gel card assay 99 100% 20 Sec + Washing Kleeenex paper towel - 1/1 NSS (Li et al. 2012) A, B, Rh Forward - - - - Kleeenex paper towel - 45/100 PSS (Li et al. 2013) A, B, Rh Forward gel card assay 98 100% 1.5 min Kleeenex paper towel - 85/100 PBS (Guan et al. 2014b) C, E, c, e, K, Jka, Jkb, M, N, S, P1, and Lea Forward gel card assay 266 100% - Kleeenex paper towel - 1/1 NSS (Li et al. 2014b) A, B, Rh Forward and Reverse conventional slide test 96 ≈ 91% 10 min Whatman No. 1 21 Days in 4 °C 1/2 NSS (Noiphung et al. 2015) C, c, E, e, K, k, Fya, Fyb, Jka, Jkb, M, N, S and s, P1, Lea and Leb Forward - 478 - - Kleeenex paper towel - 1/1 NSS, PBS (Then et al. 2015) A, B Forward and Reverse conventional slide test 76 100% 5-8 min Whatman No. 4 38 Days in 4 °C 1/4, 1/1 NSS (Songjaroen and Laiwattanapaisal 2016) D, K Forward volunteers records 210 - 7.5 min Kleenex paper towel - 1/1 NSS (Yeow et al. 2016) A, B, c, e, D, C, E, M, N, S, s, P1, Jka, Jkb, Lea, Leb, Fya, and Fyb Forward and Reverse gel card assay 3550 ≈100% 30 s Fiber glass and cotton linter 180 Days in 25 °C 45/100, 1/1 PBS (Zhang et al. 2017) A, B Forward conventional slide test 598 100% 3 min Whatman No. 113 14 Day in 4 °C 1/1 NSS (Songjaroen et al. 2018) A, B, Rh Forward conventional slide test - - 30 Sec + Washing Unrefined sisal paper - 1/2 NSS (Casals-Terré et al. 2019) A, B, Rh Forward - - - - Whatman No.1 - 1/1 NSS (Ansari et al. 2020) ABO & Rh Forward and Reverse conventional slide test - 100% Unrefined Eucalyptus papers - 1/2 NSS, PBS (Casals-Terré et al. 2020) A, B, Rh Forward - - - 30 Sec + Washing Whatman No. 4 modified with chitosan ≥ 100 days in 25 °C 1/1 NSS (Parween et al. 2020) *phosphate buffer saline, normal saline solution.
A portable microfluidic paper-based analytical device for blood detection and typing assay

Niha Ansari,Nehal Trambadiya,Anand Lodha,S. K. Menon

DOI: https://doi.org/10.1080/00450618.2020.1740321

2020-03-22

Australian Journal of Forensic Sciences

Abstract:We developed a portable device for blood detection as well as blood typing assay, using a microfluidic paper-based analytical devices (µPADs) which proves to be sensitive, cost-effective, user-friendly and field-appropriate. A different patterned µPAD was fabricated using wax and a laser printer for detection of blood and ABO and Rh blood typing. Five different blood detection tests and two blood typing systems, i.e. ABO and Rh, were performed within minutes without following any complex protocol and were simple to infer. The performance of this hand-held μPAD proves it to be a reliable alternative to lab-based tests, at a fraction of the cost and with simplicity. The developed μPAD provides on-site blood detection as well as blood typing, which proves to be a reasonable and very useful add-on to conventional forensic and clinical investigations.

medicine, legal
Flipped Quick-Response Code Enables Reliable Blood Grouping

Hong Zhang,Ruining Liu,Qingmei Li,Xiaolin Hu,Lixiang Wu,Ye Zhou,Guangchao Qing,Rui Yuan,Junjie Huang,Wei Gu,Yanyao Ye,Chao Qi,Mei Han,Xiaohui Chen,Xun Zhu,Yun Deng,Liangliang Zhang,Hengyi Chen,Haoran Zhang,Weiyin Gao,Yao Liu,Yang Luo

DOI: https://doi.org/10.1021/acsnano.1c01215

IF: 17.1

2021-04-19

ACS Nano

Abstract:Accurate and rapid blood typing plays a vital role in a variety of biomedical and forensic scenarios, but recognizing weak agglutination remains challenging. Herein, we demonstrated a flipping identification with a prompt error-discrimination (FLIPPED) platform for automatic blood group readouts. Bromocresol green dye was exploited as a characteristic chromatography indicator for the differentiation of plasma from whole blood by presenting a teal color against a brown color. After integrating these color changes into a quick-response (QR) code, prompt typing of ABO and Rhesus groups was automatically achieved and data could be uploaded wirelessly within 30 s using a commercially available smartphone to facilitate blood cross-matching. We further designed a color correction model and algorithm to remove potential errors from scanning angles and ambient light intensities, by which weak agglutination could be accurately recognized. With comparable accuracy and repeatability to classical column assay in grouping 450 blood samples, the proposed approach further demonstrates to be a versatile sample-to-result platform for clinical diagnostics, food safety, and environmental monitoring.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsnano.1c01215?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsnano.1c01215</a>.Absorbance of BCG based reaction; optimization of BCG concentration; structures of the reaction layer; optimization of sample volume; results of ABR and RBT cards; detection results of different bilirubin, total cholesterol, and HSA levels in samples; analysis of different detection angles by the BG app; reproducibility of the proposed FLIPPED assay; pseudocode for RGB calibrated algorithm; classification of data sets in SVM classifier; accuracies of the ABD, ABR, and RBT assay; detailed information on antibodies; definitions of TP, FP, TN, and FN in the machine-learning method (<a class="ext-link" href="/doi/suppl/10.1021/acsnano.1c01215/suppl_file/nn1c01215_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

materials science, multidisciplinary,chemistry, physical,nanoscience & nanotechnology
Predominance of postural imbalance in left hemiparetic patients.

Gilles Rode,C. Tiliket,Dominique Boisson

1997-03-01

Scandinavian Journal of Rehabilitation Medicine

Abstract:Postural sway characteristics in a group of 15 left hemiparetic patients were compared with those in a group of 15 right hemiparetic patients using a statokinesimetric platform. The results in the two patient groups were also compared with those derived from a group of 15 age-matched healthy control subjects. Three postural sway parameters were used: the total sway area, the anteroposterior sway and the lateral sway. Hemiparetic patients showed a larger sway area and a lateral displacement of the center of pressure toward the side of the lesion compared to normal subjects. Furthermore, left hemiparetic patients showed greater sway area and lateral displacement compared to right hemiparetic patients. We suggest that the predominance of postural imbalance in left hemiparetic patients could be due to a displacement of postural reference toward the lesion's side.
Genetic profile of RHCE, Kell, Duffy, Kidd, Diego and MNS hybrid glycophorins blood groups in ethnic northeastern Thais: Alleles, genotypes and risk of alloimmunisation

Piyapong Simtong,Amonrat Jumnainsong,Chanvit Leelayuwat

DOI: https://doi.org/10.1111/tme.13055

2024-05-29

Transfusion Medicine

Abstract:Background Antibodies against blood group antigens play a key role in the pathophysiology of haemolytic transfusion reactions (HTRs) and haemolytic disease of the fetus and newborn (HDFN). This study aimed to determine the frequencies of alleles, genotypes, and risk of alloimmunisation of clinically significant blood group systems in ethnic northeastern Thais. Methods In total, 345 unrelated, healthy, ethnic northeastern Thais were tested using the in‐house PCR‐sequence specific primers (PCR‐SSP) method for simultaneously genotyping of RHCE, Kell, Duffy, Kidd, Diego and MNS glycophorin hybrids and results confirmed by Sanger sequencing. Results In this cohort, the alleles RHCE*C (81.0%) and RHCE*e (84.8%) were more prevalent than RHCE*c (19.0%) and RHCE*E (15.2%). The most common predicted haplotype combinations of the RHCE alleles were C+c‐E−e+(R1R1) (59.4%) followed by the C+c+E+e+ (R1R2) (20.6%) and C+c+E−e+ (R1r) (11.3%). The KEL*01 allele was not found in this study. The frequencies of FY*01 and FY*02 were 88.3% and 11.7%, respectively. The genotype FY*02/02 was found in four samples (1.2%). The frequencies of JK*01 and JK*02 were 52.5% and 47.5%, respectively. Homozygous JK*02/02 was found in 81 samples (23.5%). The frequencies of DI*01 and DI*02 were 0.6% and 99.4%, respectively. In total, 64 samples (18.6%) were found to carry the MNS glycophorin hybrids. Conclusions Our results indicated a possible high risk of c, E, Fyb, Jka, Jkb and Mia alloimmunisation in these populations. Moreover, methods established for genotyping clinically significant blood groups in this study can now be utilised in routine clinical application.

hematology
Calling for diversity: improving transfusion safety through high-throughput blood group microarray genotyping

Michael Wittig,Tim Alexander Steiert,Hesham ElAbd,Frauke Degenhardt,Luca Valenti,Daniele Prati,Luisa Ronzoni,Luis Bujanda,Jesus M. Banales,Natalia Blay,Pietro Invernizzi,Maria Buti,Agustín Albillos,Javier Fernández,Nicoletta Sacchi,Antonio Julià,Anna Latiano,Rafael de Cid,Mauro D’Amato,Rosanna Asselta,Matthias Laudes,Wolfgang Lieb,David Juhl,Christoph Gassner,Andre Franke

DOI: https://doi.org/10.1101/2023.12.15.23299980

2024-03-07

Abstract:Blood transfusions, conducted between donors compatible in their red blood cell (RBC) antigens, play a life-saving role in transfusion medicine. Genetic differences at blood group loci between ethnicities result in diversity and altered frequency of RBC antigens that need to be considered in blood transfusion. Consequently, comprehensive, and accurate blood group antigen typing is especially relevant for inter-ethnic blood transfusions and for minorities underrepresented in the donor population. Blood group microarray genotyping is a cost-efficient and scalable method for comprehensive blood group typing. Previously, however, microarray typing has been challenging for the clinically important blood group systems Rh and MNS, as these feature highly paralogous genomic loci leading to mixed signals. We here present an approach for accurately typing blood group systems, including Rh and MNS variations, that we benchmarked in an ethnically diverse cohort. We tested its performance using gold-standard, diagnostic-grade MALDI-TOF data from 1,052-samples, including 334 CEPH diversity samples and applied the approach to 4,999 samples of a COVID-19 genetics study. Overall, we obtained a 99.95% benchmarking concordance and 99.65% call rate. In summary, we provide a highly accurate and cost-efficient high-throughput genotyping method for comprehensive blood group analysis that is also suitable for ethnically diverse sample sets.

Hematology
CRISPR/Cas13a-based single-nucleotide polymorphism detection for reliable determination of ABO blood group genotypes

Hongjuan Wei,Liyan Liu,Hanji Jiang,Hong Chen,Yunxiang Wang,Yongjun Han,Zhen Rong,Shengqi Wang

DOI: https://doi.org/10.1039/d3an02248j

2024-03-07

The Analyst

Abstract:The ABO blood group plays an important role in blood transfusion, linkage analysis, individual identification, etc . Serologic methods of blood typing are gold standards for the time being, which require stable typing antisera and fresh blood samples and are labor intensive. At present, reliable determination of ABO blood group genotypes based on single-nucleotide polymorphisms (SNPs) among A, B, and O alleles remains necessary. Thus, in this work, CRISPR/Cas13a-mediated genotyping for the ABO blood group by detecting SNPs between different alleles was proposed. The ABO*O.01.01(c.261delG) allele (G for the A/B allele and del for the O allele) and ABO*B.01(c.796C > A) allele (C for the A/O allele and A for the B allele) were selected to determine the six genotypes (AA, AO, BB, BO, OO, and AB) of the ABO blood group. Multiplex PCR was adapted to simultaneously amplify the two loci. CRISPR/Cas13a was then used to specifically differentiate ABO*O.01.01(c.261delG) and ABO*B.01(c.796C > A) of A, B, and O alleles. Highly accurate determination of different genotypes was achieved with a limit of detection of 50 pg per reaction within 60 min. The reliability of this method was further validated based on its applicability in detecting buccal swab samples with six genotypes. The results were compared with those of serological and sequencing methods, with 100% accuracy. Thus, the CRISPR/Cas13a-mediated assay shows great application potential in the reliable identification of ABO blood group genotypes in a wide range of samples, eliminating the need to collect fresh blood samples in the traditional method.

chemistry, analytical
Blood Group Typing: From Classical Strategies to the Application of Synthetic Antibodies Generated by Molecular Imprinting

Adnan Mujahid,Franz L. Dickert,Franz Dickert

DOI: https://doi.org/10.3390/s16010051

IF: 3.9

2015-12-31

Sensors

Abstract:Blood transfusion requires a mandatory cross-match test to examine the compatibility between donor and recipient blood groups. Generally, in all cross-match tests, a specific chemical reaction of antibodies with erythrocyte antigens is carried out to monitor agglutination. Since the visual inspection is no longer useful for obtaining precise quantitative information, therefore there is a wide variety of different technologies reported in the literature to recognize the agglutination reactions. Despite the classical methods, modern biosensors and molecular blood typing strategies have also been considered for straightforward, accurate and precise analysis. The interfacial part of a typical sensor device could range from natural antibodies to synthetic receptor materials, as designed by molecular imprinting and which is suitably integrated with the transducer surface. Herein, we present a comprehensive overview of some selected strategies extending from traditional practices to modern procedures in blood group typing, thus to highlight the most promising approach among emerging technologies.

engineering, electrical & electronic,chemistry, analytical,instruments & instrumentation
Paper-Based Microfluidic Analytical Device Patterned by Label Printer for Point-of-Care Blood Glucose and Hematocrit Detection Using 3D-Printed Smartphone Cassette

Zong-Xiao Cai,Ming-Zhang Jiang,Ya-Ju Chuang,Ju-Nan Kuo

DOI: https://doi.org/10.3390/s24154792

IF: 3.9

2024-07-25

Sensors

Abstract:This study presents a portable, low-cost, point-of-care (POC) system for the simultaneous detection of blood glucose and hematocrit. The system consists of a disposable origami microfluidic paper-based analytical device (μPAD) for plasma separation, filtration, and reaction functions and a 3D-printed cassette for hematocrit and blood glucose detection using a smartphone. The origami μPAD is patterned using a cost-effective label printing technique instead of the conventional wax printing method. The 3D-printed cassette incorporates an array of LED lights, which mitigates the effects of intensity variations in the ambient light and hence improves the accuracy of the blood glucose and hematocrit concentration measurements. The hematocrit concentration is determined quantitatively by measuring the distance of plasma wicking along the upper layer of the origami μPAD, which is pretreated with sodium chloride and Tween 20 to induce dehydration and aggregation of the red blood cells. The filtered plasma also penetrates to the lower layer of the origami μPAD, where it reacts with embedded colorimetric assay reagents to produce a yellowish-brown complex. A color image of the reaction complex is captured using a smartphone inserted into the 3D-printed cassette. The image is analyzed using self-written RGB software to quantify the blood glucose concentration. The calibration results indicate that the proposed detection platform provides an accurate assessment of the blood glucose level over the range of 45–630 mg/dL (R2 = 0.9958). The practical feasibility of the proposed platform is demonstrated by measuring the blood glucose and hematocrit concentrations in 13 human whole blood samples. Taking the measurements obtained from commercial glucose and hematocrit meters as a benchmark, the proposed system has a differential of no more than 6.4% for blood glucose detection and 9.1% for hematocrit detection. Overall, the results confirm that the proposed μPAD is a promising solution for cost-effective and reliable POC health monitoring.

engineering, electrical & electronic,chemistry, analytical,instruments & instrumentation
A machine-learning method for biobank-scale genetic prediction of blood group antigens

Kati Hyvärinen,Katri Haimila,Camous Moslemi,Blood Service Biobank,Martin L. Olsson,Sisse R. Ostrowski,Ole B. Pedersen,Christian Erikstrup,Jukka Partanen,Jarmo Ritari

DOI: https://doi.org/10.1371/journal.pcbi.1011977

2024-03-22

PLoS Computational Biology

Abstract:A key element for successful blood transfusion is compatibility of the patient and donor red blood cell (RBC) antigens. Precise antigen matching reduces the risk for immunization and other adverse transfusion outcomes. RBC antigens are encoded by specific genes, which allows developing computational methods for determining antigens from genomic data. We describe here a classification method for determining RBC antigens from genotyping array data. Random forest models for 39 RBC antigens in 14 blood group systems and for human platelet antigen (HPA)-1 were trained and tested using genotype and RBC antigen and HPA-1 typing data available for 1,192 blood donors in the Finnish Blood Service Biobank. The algorithm and models were further evaluated using a validation cohort of 111,667 Danish blood donors. In the Finnish test data set, the median (interquartile range [IQR]) balanced accuracy for 39 models was 99.9 (98.9–100)%. We were able to replicate 34 out of 39 Finnish models in the Danish cohort and the median (IQR) balanced accuracy for classifications was 97.1 (90.1–99.4)%. When applying models trained with the Danish cohort, the median (IQR) balanced accuracy for the 40 Danish models in the Danish test data set was 99.3 (95.1–99.8)%. The RBC antigen and HPA-1 prediction models demonstrated high overall accuracies suitable for probabilistic determination of blood groups and HPA-1 at biobank-scale. Furthermore, population-specific training cohort increased the accuracies of the models. This stand-alone and freely available method is applicable for research and screening for antigen-negative blood donors. Blood transfusion is one of the most common clinical procedures in the hospitals and the key element for safe transfusion is compatibility between the recipient and donor red blood cell antigens. Precise antigen matching reduces the risk for sensitization and other adverse transfusion outcomes. Here we describe a stand-alone and freely available random forest classification method and models for determining red blood cell and human platelet antigens from array technology-based genotyping data. We investigate the performance of models trained with Finnish blood donor biobank data and further validate the method with a large Danish cohort. The results demonstrate high overall accuracy, and the method is suitable for biobank-scale research and screening of antigen-negative donors. The implementation is possible in the local computing environment without sensitive data uploads and requires only a moderate level of bioinformatic skills.

biochemical research methods,mathematical & computational biology
Rapid and Direct Detection of Apolipoprotein E Genotypes Using Whole Blood from Humans

Suhng Wook Kim,Ji Hye Heo,Chun Huem Kim,Dong Chul Yoo,Dong Hwan Won,Seung Gwan Lee,Kyoung Jin Cho,Jung Han Song,Su Jeong Park,Young Geun Yang,Dal Woong Choi

DOI: https://doi.org/10.1080/15287394.2010.511573

2010-11-01

Abstract:Polymerase chain reaction (PCR) is a powerful molecular biological tool in the field of toxicity testing and diagnostics. The use of PCR for large-scale genetic testing requires an effective method of sample processing. Unfortunately, isolation of PCR-quality DNA is time-consuming. PCR performed directly on whole blood is preferred because of time efficiency, cost of the procedure, and possible automation for large-scale toxicity evaluation and diagnosis. The apolipoprotein E (APOE) gene contains two single-nucleotide polymorphisms (SNP) located at codons 112 and 158, producing three APOE protein isoforms known to be associated with the risks of developing cardiovascular disease and susceptibility to Alzheimer's disease. In the present study, an attempt was made to use the AnyDirect solution for APOE genotyping by PCR using whole blood directly without DNA purification. Results for two PCR methods, (1) conventional PCR using purified DNA and conventional buffer and (2) direct PCR using whole blood and AnyDirect solution, were compared in four different PCR-based APOE genotyping methods including PCR restriction-fragment-length polymorphism (PCR-RFLP), allele-specific PCR, SNaPshot mini-sequencing, and multiplex tetra-primer amplification refractory mutation system (T-ARMS) PCR. There was complete concordance in the APOE genotypes between conventional PCR and direct PCR, in all four different PCR-based APOE genotyping methods. Data demonstrated that the four different PCR-based APOE genotyping methods are able to determine the APOE genotypes successfully using whole blood directly with the use of AnyDirect solution. The direct multiplex T-ARMS PCR using whole blood may be the most rapid, simple, and inexpensive method for detecting APOE genotypes among four different APOE genotyping methods.

public, environmental & occupational health,toxicology,environmental sciences
Assessment of common red blood cell pretreatments to yield an accurate serologic antigen phenotype compared with genotype-predicted phenotype

T Horn,J Hamilton,J Kosanke,V W Hare,W Kluver,W Beres,S Nance,M A Keller

DOI: https://doi.org/10.21307/immunohematology-2019-020

Immunohematology

Abstract:For patients requiring multiple transfusions and patients with positive direct antiglobulin tests (DATs), an extended red blood cell (RBC) phenotype can provide valuable information and help to determine the risk of forming alloantibodies. In some instances, the phenotype may be used for prophylactic matching. Phenotyping in this patient population is often hindered by the presence of circulating donor cells and/or by a positive DAT. Several methods, such as EDTA glycine acid (EGA) treatment to remove IgG, hypotonic saline wash to separate autologous RBCs, or reticulocyte separation, are often used in these situations to isolate patient RBCs for serologic phenotyping. This study aimed to determine the accuracy of each RBC pretreatment method by comparing serologically determined antigen types with those predicted by RBC genotyping. Forty-eight peripheral blood samples from recently transfused patients were phenotyped for selected antigens in the Rh, Kell, MNS, Duffy, and Kidd systems. Treatment methods for the sample sets were reticulocyte separation (N = 12), EGA (N = 16), and hypotonic saline wash (N = 20). DNA was extracted using standard methods, and genotyping was performed using the HEA BeadChip panel. In addition, 21 samples positive for RBC-bound IgG were EGA-treated up to two times. These samples were analyzed pre- and post-EGA treatment for RBC-bound IgG by tube DAT and by flow cytometry with fluorescein isothiocyanate-labeled anti-human IgG. After reticulocyte separation, 3 of the 12 samples had discordant types with one antigen each: Fyb, N, and K; serologic results were negative compared with genotype-predicted positive phenotype results. The EGA-treated sample set showed one discordant type: Fyb; serologic results were negative compared with genotype-predicted positive phenotype results. Four of the 20 samples had discordant types involving the following antigens: Fyb, N, e, and M; serologic results were negative compared with genotype-predicted positive phenotype results. After EGA treatment of 21 samples, 14 (67%) were negative for RBC-bound IgG by tube DAT, and 7 remained positive. Using flow cytometry, EGA treatment rendered only 4 samples negative, and 17 remained positive. In the antigen testing sample set of 48 samples, 10 of 511 total antigen types tested were discordant. Discordant types were most frequent in the hypotonic saline wash sample set (N = 6). In the flow cytometry sample set, 48 percent of the samples negative by tube DAT after EGA elution had detectable RBC-bound IgG by flow cytometry. These findings suggest that caution should be taken when using phenotype results from all pretreated RBCs and support the use of RBC genotyping to predict RBC antigen expression in samples from recently transfused patients. For patients requiring multiple transfusions and patients with positive direct antiglobulin tests (DATs), an extended red blood cell (RBC) phenotype can provide valuable information and help to determine the risk of forming alloantibodies. In some instances, the phenotype may be used for prophylactic matching. Phenotyping in this patient population is often hindered by the presence of circulating donor cells and/or by a positive DAT. Several methods, such as EDTA glycine acid (EGA) treatment to remove IgG, hypotonic saline wash to separate autologous RBCs, or reticulocyte separation, are often used in these situations to isolate patient RBCs for serologic phenotyping. This study aimed to determine the accuracy of each RBC pretreatment method by comparing serologically determined antigen types with those predicted by RBC genotyping. Forty-eight peripheral blood samples from recently transfused patients were phenotyped for selected antigens in the Rh, Kell, MNS, Duffy, and Kidd systems. Treatment methods for the sample sets were reticulocyte separation (N = 12), EGA (N = 16), and hypotonic saline wash (N = 20). DNA was extracted using standard methods, and genotyping was performed using the HEA BeadChip panel. In addition, 21 samples positive for RBC-bound IgG were EGA-treated up to two times. These samples were analyzed pre- and post-EGA treatment for RBC-bound IgG by tube DAT and by flow cytometry with fluorescein isothiocyanate–labeled anti-human IgG. After reticulocyte separation, 3 of the 12 samples had discordant types with one antigen each: Fyb, N, and K; serologic results were negative compared with genotype-predicted positive phenotype results. The EGA-treated sample set showed one discordant type: Fyb; serologic results were negative compared with genotype-predicted positive phenotype results. Four of the 20 samples had discordant types involving the following antigens: Fyb, N, e, and M; serologic results were negative compared with genotype-predicted positive phenotype results. After EGA treatment of 21 samples, 14 (67%) were negative for RBC-bound IgG by tube DAT, and 7 remained positive. Using flow cytometry, EGA treatment rendered only 4 samples negative, and 17 remained positive. In the antigen testing sample set of 48 samples, 10 of 511 total antigen types tested were discordant. Discordant types were most frequent in the hypotonic saline wash sample set (N = 6). In the flow cytometry sample set, 48 percent of the samples negative by tube DAT after EGA elution had detectable RBC-bound IgG by flow cytometry. These findings suggest that caution should be taken when using phenotype results from all pretreated RBCs and support the use of RBC genotyping to predict RBC antigen expression in samples from recently transfused patients.
Preparation and photocatalytic activity of an electrostatically self-assembled film made of [PMo12O40](3-) and a bipolar hemicyanine cation.

Lihua Gao,Wen Jiang,Ke-Zhi Wang

DOI: https://doi.org/10.1166/JNN.2011.5313

2011-11-01

Journal of Nanoscience and Nanotechnology

Abstract:An electrostatically self-assembled film of PMo12/H6 has successfully been prepared on quartz substrates by alternating adsorption of [PMo12O40(3-) (PMo12) and a bipolar hemicyanine derivative of (E)-1,1'-(hexane-1,6-diyl)bis(4-(4-(dimethylamino)styryl)pyridinium) bromide (H6Br2). The UV-visible spectra showed that the film was uniformly deposited and the charge transfer between two film-forming components might occur in the film. The photocatalytic performance of the film was studied for the degradation of aqueous dye Methyl Red (MR) under UV irradiation. The degradation of MR follows Langmuir-Hinshelwood first-order kinetics.
Red blood cell extended antigen typing in Omani patients with sickle cell disease to enhance daily transfusion practice

Amal Salim Al Breiki,Salam Al Kindi,Lilian Castilho

DOI: https://doi.org/10.2478/immunohematology-2024-0014

2024-10-04

Immunohematology

Abstract:Many Omani patients with sickle cell disease (SCD) undergo red blood cell (RBC) transfusions that are only matched for ABO and D, making RBC alloimmunization a significant concern in this population. Currently, the integration of molecular assays and hemagglutination testing helps to determine RBC phenotypes and genotypes, facilitating the provision of compatible blood and minimizing additional alloimmunization risks in patients with SCD. Based on this finding, our objective was to use molecular methods to predict the extended antigen profile of Omani patients with SCD across various blood group systems including Rh, Kell, Duffy, Kidd, Colton, Lutheran, Dombrock, Diego, Cartwright, and Scianna. This approach aims to implement RBC matching strategies and enhance daily transfusion practices for these patients. Molecular methods encompassed multiplex polymerase chain reaction for RHD, BeadChip arrays for variants of RHD and RHCE, and ID CORE XT for the primary allelic variants of RBCs. This study enrolled 38 patients with SCD, comprising 34 patients with homozygous HbSS, 1 patient with HbSC, and 3 patients with HbS Oman. The predominant ABO blood group was group O, observed in 44.7 percent of patients, followed by group A in 21.1 percent and group B in 13.2 percent. The most prevalent Rh phenotype predicted from the genotype was D+C+E-c+e+, identified in 34.2 percent of patients. All patient samples were K-, exhibiting the k+ Kp(b+) Js(b+) phenotype, with 81.6 percent demonstrating Fy(a-b-) due to the homozygous FY*02N.01 genotype and 28.9 percent displaying Jk(a+b-). RH variant alleles were detected in five patients (13.2 %), with only one type of RHD variant (RHD*DIIIa) and one type of RHCE variant (RHCE*ceVS.02.01) identified. Alloantibodies were present in 26 patients (68.4%). This study presents the initial comprehensive report of extended RBC antigen profiling in Omani patients with SCD, revealing disparities in the prevalence of RBC phenotypes compared with SCD patients from other regions and countries. Furthermore, our findings underscore a high rate of alloimmunization in these patients, emphasizing the need to implement antigen-matching programs to improve daily transfusion practices.
Rapid parallel blood typing on centrifugal microfluidic platform by microcolumn gel immunoassay

Yaru Wan,Mingyu Zhang,Zetai Liu,Bangfeng Wang,Yangcheng Liu,Peng Chen,Yiwei Li,Wei Du,Xiaojun Feng,Bi-Feng Liu

DOI: https://doi.org/10.1016/j.talanta.2024.126959

IF: 6.1

2024-09-28

Talanta

Abstract:Microcolumn gel immunoassay (MGIA) has the ability to meet the requirements of clinical diagnosis due to its reliable sensitivity and accuracy. However, traditional MGIA exhibits limitations including inadequate portability, low throughput, and extended analysis time. To address these challenges, we combined MGIA with microfluidic technology, demonstrating a centrifugal microfluidic-based microcolumn gel immunoassay (μMGIA) platform for blood typing of clinical samples. Experimental results indicate that the μMGIA platform can simultaneously detect six blood group antigens in five clinical blood samples within 2 min. Notably, it offers comprehensive detection of ABO blood group antigens and Rh blood group antigens with 100 % accuracy, outperforming the traditional slide method. The integration of microfluidic technology with MGIA circumvents the constraints of traditional methods, providing a new avenue for blood typing and immunoanalysis of clinical samples.

chemistry, analytical
Fully genotyping and screening of clinically important blood‐group antigens by MALDI TOF mass spectrometry

Qixiu Yang,Aijing Li,Chen Wang,Jiaxuan Yang,Minghao Li,Huijun Zhu,Daru Lu,Ziyan Zhu,Luyi Ye

DOI: https://doi.org/10.1002/elps.202300138

2024-01-09

Electrophoresis

Abstract:Several molecular biology methods are available for high‐throughput blood typing. In this study, we aimed to build a high‐throughput blood‐group genetic screening system for high‐frequency blood‐group antigen‐negative rare‐blood groups in donors and patients. The amplification primers for all blood‐type gene fragments involving the selected alleles were designed for detection. Single‐base extend primers were also designed based on specific loci. DNA fragments were detected by matrix‐assisted laser desorption/ionization time‐of‐flight mass spectrometry (MS) for the last nucleotide identification of amplification products in the extend step. The accuracy was verified by known samples. Thirty‐six random samples were detected by serological tests and sequencing to verify the system stability. After verification, according to the collected known rare‐blood‐type samples, all the alleles designed to be detected matched with the validated single‐nucleotide polymorphisms. The verification tests showed that all genotyping results of the random samples were in accordance with the findings of serotyping and sequencing. Then, 1258 random donor samples were screened by the built typing system after the verification. Three Fy(a−) and four s− were screened out in 1258 random blood samples. The multiple polymerase chain reaction‐based MS detection system can be used in rare‐blood‐type screening with good accuracy and stability.

biochemical research methods,chemistry, analytical
Paper-based Analytical Devices for Point-of-care Blood Tests.

Hao Yuan,Ping-Yeh Chiu,Chien-Fu Chen

DOI: https://doi.org/10.1063/5.0055601

2021-01-01

Biomicrofluidics

Abstract:Blood can be a window to health, and as a result, is the most intensively studied human biofluid. Blood tests can diagnose diseases, monitor therapeutic drugs, and provide information about the health of an individual. Rapid response blood tests are becoming increasingly essential, especially when subsequent treatment is required. Toward this need, paper-based devices have been excellent tools for performing blood tests due to their ability to conduct rapid and low-cost diagnostics and analyses in a non-laboratory environment. In this Perspective, we review recent advances in paper-based blood tests, particularly focusing on the specific techniques and assays applied. Additionally, we discuss the future of these paper-based devices, such as how the signal intensity can be enhanced and how the in situ synthesis of nanomaterials can be used to improve the sensitivity, functionality, and operational simplicity. With these advances, paper-based devices are becoming increasingly valuable tools for point-of-care blood tests in various practical scenarios.
Use of quill comb in the diagnosis of ectoparasites

G. Walton

DOI: https://doi.org/10.1136/VR.97.23.454

1975-12-06

Abstract:
Confounding by indication?

S. Shapiro

Epidemiology

Abstract:
Derek C. Harwood-Nash, M.B., CH.B., D.SC. 1936–1996

D. Kirks

DOI: https://doi.org/10.1007/BF03036376

1997-02-01

Pediatric Radiology

Abstract:

Alterations in plasma angiogenic growth factor concentrations after coronary artery bypass graft surgery: relationships with post-operative complications.

Paper based analytical devices for blood grouping: a comprehensive review

A portable microfluidic paper-based analytical device for blood detection and typing assay

Flipped Quick-Response Code Enables Reliable Blood Grouping

Predominance of postural imbalance in left hemiparetic patients.

Genetic profile of RHCE, Kell, Duffy, Kidd, Diego and MNS hybrid glycophorins blood groups in ethnic northeastern Thais: Alleles, genotypes and risk of alloimmunisation

Calling for diversity: improving transfusion safety through high-throughput blood group microarray genotyping

CRISPR/Cas13a-based single-nucleotide polymorphism detection for reliable determination of ABO blood group genotypes

Blood Group Typing: From Classical Strategies to the Application of Synthetic Antibodies Generated by Molecular Imprinting

Paper-Based Microfluidic Analytical Device Patterned by Label Printer for Point-of-Care Blood Glucose and Hematocrit Detection Using 3D-Printed Smartphone Cassette

A machine-learning method for biobank-scale genetic prediction of blood group antigens

Rapid and Direct Detection of Apolipoprotein E Genotypes Using Whole Blood from Humans

Assessment of common red blood cell pretreatments to yield an accurate serologic antigen phenotype compared with genotype-predicted phenotype

Preparation and photocatalytic activity of an electrostatically self-assembled film made of [PMo12O40](3-) and a bipolar hemicyanine cation.

Red blood cell extended antigen typing in Omani patients with sickle cell disease to enhance daily transfusion practice

Rapid parallel blood typing on centrifugal microfluidic platform by microcolumn gel immunoassay

Fully genotyping and screening of clinically important blood‐group antigens by MALDI TOF mass spectrometry

Paper-based Analytical Devices for Point-of-care Blood Tests.

Use of quill comb in the diagnosis of ectoparasites

Confounding by indication?

Derek C. Harwood-Nash, M.B., CH.B., D.SC. 1936–1996